Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Percutaneous balloon valvuloplasty.

R A Nishimura1, D R Holmes, G S Reeder

  • 1Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905.

Mayo Clinic Proceedings
|February 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiac catheterization reduces resource utilization in patients with chronic chest pain.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2001
Same author

Primary angioplasty for acute myocardial infarction in the elderly.

Coronary artery disease·2000
Same author

Prediction of death after percutaneous coronary interventional procedures.

American heart journal·2000
Same author

Diabetes mellitus and outcome after primary coronary angioplasty for acute myocardial infarction: lessons from the GUSTO-IIb Angioplasty Substudy. Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes.

Journal of the American College of Cardiology·2000
Same author

Attenuated coronary flow reserve and vascular remodeling in patients with hypertension and left ventricular hypertrophy.

Journal of the American College of Cardiology·2000
Same author

Reduced thrombus burden with abciximab delivered locally before percutaneous intervention in saphenous vein grafts.

American heart journal·2000
Same journal

Thyroid Dysfunction and the Risk of Clinically Relevant Depression: A Longitudinal Cohort Study.

Mayo Clinic proceedings·2026
Same journal

37-Year-Old Woman With Jaundice.

Mayo Clinic proceedings·2026
Same journal

34-Year-Old Woman With An Unidentified Overdose.

Mayo Clinic proceedings·2026
Same journal

Use of Bronchoscopic Cryobiopsy in Evaluating Interstitial Lung Disease: Radiologic Predictors of Diagnostic Yield and Safety.

Mayo Clinic proceedings·2026
Same journal

Advancing Pulmonary Fibrosis Care: Integrating Genomic Insights Into Clinical Practice.

Mayo Clinic proceedings·2026
Same journal

RAAS Inhibition in the ICU: Stop, Continue, or Restart?

Mayo Clinic proceedings·2026
See all related articles

Percutaneous balloon valvuloplasty offers excellent results for pulmonic stenosis and can be effective for mitral stenosis in select patients. Its role in aortic stenosis is palliative for high-risk individuals.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Percutaneous balloon valvuloplasty is a minimally invasive procedure to treat stenotic heart valves.
  • The technique involves inflating balloons across narrowed valves to reduce obstruction.

Purpose of the Study:

  • To evaluate the efficacy and outcomes of percutaneous balloon valvuloplasty across different stenotic heart valves.
  • To determine the suitability of balloon valvuloplasty based on valve type, patient age, and valve morphology.

Main Methods:

  • Balloon valvuloplasty performed percutaneously across pulmonic, mitral, and aortic valves.
  • Outcomes assessed based on valve type, patient demographics, and valve characteristics.

Main Results:

Related Experiment Videos

  • Excellent and safe outcomes reported for pulmonic stenosis, making it a preferred treatment.
  • Mitral stenosis outcomes depend on valve morphology; best for pliable, non-calcified valves or high-risk patients.
  • Aortic stenosis treatment is limited to high-risk or non-surgical elderly patients, providing palliative benefits despite high short-term complication rates.

Conclusions:

  • Balloon valvuloplasty is a highly effective treatment for pulmonic stenosis.
  • Its success in mitral stenosis is contingent on valve characteristics and patient selection.
  • For aortic stenosis, it offers palliation in select high-risk populations, with long-term efficacy requiring further study.